Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2026-01-01 @ 12:17 PM
Study NCT ID:
NCT05592756
Status:
COMPLETED
Last Update Posted:
2023-06-13
First Post:
2022-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases Confirmed
Sponsor:
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-06
Start Date Type:
ACTUAL
Primary Completion Date:
2021-08-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2022-10-20
First Submit QC Date:
None
Study First Post Date:
2022-10-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-12
Last Update Post Date:
2023-06-13
Last Update Post Date Type:
ACTUAL